Epidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients - Egyptian Knowledge Bank - troweb

43853

Epidermal growth factor (EGF) gene polymorphism as a risk factor for development of hepatocellular carcinoma (HCC) in chronic liver disease patients

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Expression of epidermal growth factor receptor and transforming growth factor –alpha in chronic viral C hepatitis

Thesis

Vascular endothelial growth factor 634G/C gene polymorphism in prognosis of hepatocellular carcinoma in Egyptian patients

Thesis

The role of glutathione -S- transferase gene mutation in the development of hepatocellular carcinoma

Thesis

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Thesis

Study of heat shock protein a1b 1267 polymorphism in hepatocellular carcinoma

Thesis

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Thesis

Genetic mutation study among hepatocellular carcinoma patients (Case – control) study

Thesis

Association of single nucleotide polymorphism of SPARC gene with increased risk of hepatocellular carcinoma

Thesis

Clinical biochemical markers for hepatocellular carcinoma in Egyptian patients

Thesis

Basic fibroblast growth factorin chronic liver diseases andhepatocellular carcinoma